The Cell and Gene Therapy Catapult (CGT Catapult), German CDMO Rentschler Biopharma and mass photometry pioneer Refeyn Ltd (Oxford), are combining their expertise in manufacturing and process analytical technologies (PAT) to improve the efficiency of adeno-associated viruses (AAV) manufacture. Click to read more.
EQS-News: Rentschler Biopharma SE / Key word(s): Alliance Rentschler implements innovative learning program in collaboration with MassBioEd and WPI 07.12.2022 / 15:00 CET/CEST The issuer is solely responsible for the content of this announcement. Rentschler implements innovative learning program.
DGAP-News: Rentschler Biopharma SE / Key word(s): Personnel Rentschler Biopharma adds highly experienced executive to team and provides update on progress at Rentschler ATMP 13.06.2022 / 16:00 The issuer is solely responsible for the content of this announcement. Rentschler Biopharma adds highly.
Rentschler Biopharma and Vetter, two globally operating Contract Development and Manufacturing Organizations (CDMOs), announced today that the companies are unveiling Xpert Alliance, a joint visualization